1. Home
  2. CNTA vs VVX Comparison

CNTA vs VVX Comparison

Compare CNTA & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • VVX
  • Stock Information
  • Founded
  • CNTA 2020
  • VVX 2014
  • Country
  • CNTA United Kingdom
  • VVX United States
  • Employees
  • CNTA N/A
  • VVX N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • VVX Diversified Commercial Services
  • Sector
  • CNTA Health Care
  • VVX Consumer Discretionary
  • Exchange
  • CNTA Nasdaq
  • VVX Nasdaq
  • Market Cap
  • CNTA 1.6B
  • VVX 1.4B
  • IPO Year
  • CNTA 2021
  • VVX 2014
  • Fundamental
  • Price
  • CNTA $14.29
  • VVX $49.21
  • Analyst Decision
  • CNTA Strong Buy
  • VVX Buy
  • Analyst Count
  • CNTA 10
  • VVX 9
  • Target Price
  • CNTA $28.78
  • VVX $64.11
  • AVG Volume (30 Days)
  • CNTA 980.2K
  • VVX 251.1K
  • Earning Date
  • CNTA 08-12-2025
  • VVX 08-04-2025
  • Dividend Yield
  • CNTA N/A
  • VVX N/A
  • EPS Growth
  • CNTA N/A
  • VVX N/A
  • EPS
  • CNTA N/A
  • VVX 1.29
  • Revenue
  • CNTA $15,000,000.00
  • VVX $4,327,514,000.00
  • Revenue This Year
  • CNTA N/A
  • VVX $4.02
  • Revenue Next Year
  • CNTA N/A
  • VVX $4.80
  • P/E Ratio
  • CNTA N/A
  • VVX $38.10
  • Revenue Growth
  • CNTA 118.88
  • VVX 7.38
  • 52 Week Low
  • CNTA $9.00
  • VVX $41.08
  • 52 Week High
  • CNTA $19.09
  • VVX $69.75
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 61.38
  • VVX 58.54
  • Support Level
  • CNTA $13.22
  • VVX $48.84
  • Resistance Level
  • CNTA $14.74
  • VVX $50.29
  • Average True Range (ATR)
  • CNTA 0.73
  • VVX 1.22
  • MACD
  • CNTA 0.14
  • VVX 0.26
  • Stochastic Oscillator
  • CNTA 85.11
  • VVX 76.55

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

Share on Social Networks: